There is some evidence to suggest that cannabis or cannabinoid-based medications may be useful in the treatment of glaucoma, a condition that involves increased pressure in the eye that can damage the optic nerve and lead to vision loss. Some research has found that THC, the psychoactive component of cannabis, may help to lower intraocular pressure (IOP) in the eye, which is one of the main risk factors for the development and progression of glaucoma.
However, it is important to note that the evidence supporting the use of cannabis in the treatment of glaucoma is limited and more research is needed to fully understand its potential benefits and risks. In addition, the effects of cannabis on IOP and glaucoma may vary depending on the individual and the specific strain of cannabis being used.
If you are considering using cannabis or cannabinoid-based medications for the treatment of glaucoma, it is important to talk to your healthcare provider about the potential risks and benefits. Your healthcare provider can help you to determine the most appropriate treatment approach for your specific situation.
What Cannabinoid Helps with Glaucoma?
Previous studies have shown that cannabinoids have therapeutic value for treating glaucoma by lowering IOP. WIN 55,212-2, a CB1 agonist, and 9-tetrahydrocannabinol (9-THC), a phytocannabinoid, are two examples of the exogenous substances mentioned and mentioned.
Does CBD Reduce Eye Pressure?
The bulk of the research indicates that CBD is ineffective at reducing ocular pressure. The evidence from the available research, however, shows that THC does reduce IOP in contrast to CBD (the ineffectiveness of topical drops notwithstanding)
